These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12057091)

  • 1. Elderly patients with lung cancer: biases and evidence.
    Langer CJ
    Curr Treat Options Oncol; 2002 Feb; 3(1):85-102. PubMed ID: 12057091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic overview of chemotherapy effects in non-small cell lung cancer.
    Sörenson S; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):327-39. PubMed ID: 11441939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.
    Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C
    J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I
    Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neglected and underrepresented subpopulations: elderly and performance status 2 patients with advanced-stage non-small-cell lung cancer.
    Langer CJ
    Clin Lung Cancer; 2006 May; 7 Suppl 4():S126-37. PubMed ID: 16764753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies].
    Langer F; Helsberg K; Schütte WH; Leschinger MI
    Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal pharmacotherapeutic strategies for elderly patients with advanced non-small cell lung cancer.
    Quoix E
    Drugs Aging; 2011 Nov; 28(11):885-94. PubMed ID: 22054229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined-modality treatment of locally advanced non-small cell lung cancer: incorporation of novel chemotherapeutic agents.
    Belani CP; Ramanathan RK
    Chest; 1998 Jan; 113(1 Suppl):53S-60S. PubMed ID: 9438691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined modality therapy of lung cancer.
    Livingston RB
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: a meta-analysis.
    Des Guetz G; Uzzan B; Nicolas P; Valeyre D; Sebbane G; Morere JF
    Crit Rev Oncol Hematol; 2012 Dec; 84(3):340-9. PubMed ID: 22534083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of lung cancer in elderly part II: small cell lung cancer.
    Weinmann M; Jeremic B; Bamberg M; Bokemeyer C
    Lung Cancer; 2003 Apr; 40(1):1-16. PubMed ID: 12660002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer.
    Coate LE; Massey C; Hope A; Sacher A; Barrett K; Pierre A; Leighl N; Brade A; de Perrot M; Waddell T; Liu G; Feld R; Burkes R; Cho BC; Darling G; Sun A; Keshavjee S; Bezjak A; Shepherd FA
    J Thorac Oncol; 2011 Mar; 6(3):537-44. PubMed ID: 21258243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer in the elderly: current and future chemotherapeutic options.
    Hinton S; Sandler A
    Drugs Aging; 2002; 19(5):365-75. PubMed ID: 12093323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of advanced non-small-cell lung cancer in elderly populations.
    Lilenbaum R
    Clin Lung Cancer; 2003 Nov; 5(3):169-73. PubMed ID: 14667272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of unresected stage III non-small cell lung cancer: a systematic review.
    Okawara G; Mackay JA; Evans WK; Ung YC;
    J Thorac Oncol; 2006 May; 1(4):377-93. PubMed ID: 17409887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy in elderly patients with advanced lung cancer. Part II: Treatment of non-small cell lung cancer (NSCLC).
    Honecker F; Wedding U; Bokemeyer C;
    Onkologie; 2004 Dec; 27(6):583-8. PubMed ID: 15591721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: An open phase II study using concurrent cisplatin-oral vinorelbine and radiotherapy (GFPC 08-06).
    Locher C; Pourel N; Le Caer H; Berard H; Auliac JB; Monnet I; Descourt R; Vergnenègre A; Lafay IM; Greillier L; Chouaïd C
    Lung Cancer; 2018 Jul; 121():25-29. PubMed ID: 29858022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada.
    Cuffe S; Booth CM; Peng Y; Darling GE; Li G; Kong W; Mackillop WJ; Shepherd FA
    J Clin Oncol; 2012 May; 30(15):1813-21. PubMed ID: 22529258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer in the elderly.
    Gridelli C; Langer C; Maione P; Rossi A; Schild SE
    J Clin Oncol; 2007 May; 25(14):1898-907. PubMed ID: 17488989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.